Shelter Pharma Stock Price Analysis and Quick Research Report. Is Shelter Pharma an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Shelter Pharma. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Shelter Pharma has a PE ratio of 7.22090868426098 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Shelter Pharma has ROA of 20.9015% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Shelter Pharma has a Current ratio of 20.1498.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Shelter Pharma has a ROE of 25.5779%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Shelter Pharma has a Debt to Equity ratio of 0.0166 which means that the company has low proportion of debt in its capital.

• Sales growth: Shelter Pharma has reported revenue growth of 10.7051% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Shelter Pharma for the current financial year is 21.95218237559%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Shelter Pharma is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Shelter Pharma is Rs 6.2596. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Shelter Pharma in Ticker for free. Also, one can get the intrinsic value of Shelter Pharma by using Valuation Calculators, which are available with a Finology ONE subscription. 

Shelter Pharma FAQs

Q1. What is Shelter Pharma share price today?
Ans: The current share price of Shelter Pharma is Rs 45.2.

Q2. What is the market capitalisation of Shelter Pharma?
Ans: Shelter Pharma has a market capitalisation of Rs 52.25025984 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Shelter Pharma?
Ans: The PE ratio of Shelter Pharma is 7.22090868426098 and the P/B ratio of Shelter Pharma is 1.49825645377282, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Shelter Pharma share?
Ans: The 52-week high share price of Shelter Pharma is Rs 69.7, and the 52-week low share price of Shelter Pharma is Rs 35.7.

Q5. Does Shelter Pharma pay dividends?
Ans: Currently, Shelter Pharma does not pay dividends. Dividend yield of Shelter Pharma is around 0%.

Q6. What are the face value and book value of Shelter Pharma shares?
Ans: The face value of Shelter Pharma shares is Rs 10, while the book value per share of Shelter Pharma is around Rs 30.1684. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Shelter Pharma?
Ans: Shelter Pharma has a total debt of Rs 0.5773 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Shelter Pharma?
Ans: The ROE of Shelter Pharma is 25.5779% and ROCE of Shelter Pharma is 33.6184%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Shelter Pharma a good buy for the long term?
Ans: The Shelter Pharma long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Shelter Pharma undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Shelter Pharma appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Shelter Pharma’s financials?
Ans: You can review Shelter Pharma’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.